Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
SONIC SOLUTIONS (SNIC)
|
Add to portfolio |
|
|
|
| Price: |
$14.77
| | Metrics |
| OS: |
26.6
|
M
| |
1
|
% ROE
|
| Market cap: |
$393
|
M
| |
2
|
% ROIC
|
|
Net cash:
|
$46.6
|
M
| |
$1.75
|
per share
|
|
EV:
|
$347
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($20.3)
|
M
| |
|
|
|
EBIT
|
($23.4)
|
M
| |
|
|
| EPS |
$0.01
| |
1466.1
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Mar-31-10 | Mar-31-09 | Mar-31-08 | Mar-31-07 | Mar-31-06 | Mar-31-05 | Mar-31-04 | Mar-31-03 |
| Revenues | 104.3 | 120.0 | 132.9 | 148.6 | 147.6 | 90.6 | 56.9 | 32.7 |
| Revenue growth | -13.0% | -9.7% | -10.6% | 0.7% | 62.9% | 59.4% | 73.8% | 71.3% |
| Cost of goods sold | 31.9 | 32.9 | 33.2 | 34.4 | 34.1 | 13.4 | 7.1 | 7.4 |
| Gross profit | 72.5 | 87.1 | 99.7 | 114.3 | 113.5 | 77.3 | 49.8 | 25.3 |
| Gross margin | 69.5% | 72.6% | 75.1% | 76.9% | 76.9% | 85.2% | 87.6% | 77.2% |
| Sales and marketing | 30.0 | 35.8 | 36.2 | 33.3 | 35.6 | 1.3 | 12.6 | 8.8 |
| Research and development | 24.7 | 39.3 | 44.5 | 44.5 | 44.2 | 1.5 | 19.7 | 10.6 |
| General and administrative | 17.7 | 24.2 | 27.3 | 20.5 | 22.2 | 1.6 | 4.7 | 3.1 |
| EBIT | 0.1 | -12.2 | -8.3 | 14.9 | 11.2 | 7.4 | 12.8 | 2.8 |
| EBIT margin | 0.1% | -10.1% | -6.2% | 10.1% | 7.6% | 8.2% | 22.5% | 8.5% |
| Pre-tax income | -0.8 | -93.0 | -9.8 | 12.3 | 10.2 | 4.5 | 13.0 | 2.7 |
| Income taxes | 0.5 | 25.2 | -4.3 | 6.1 | -9.2 | 1.8 | 1.9 | 0.2 |
| Tax rate | | | 43.4% | 49.3% | | 39.2% | 14.8% | 7.3% |
| Net income | -1.2 | -118.1 | -5.5 | 6.3 | 19.3 | 2.7 | 11.1 | 0.0 |
| Net margin | -1.2% | -98.5% | -4.2% | 4.2% | 13.1% | 3.0% | 19.5% | 0.0% |
| |
| Diluted EPS | ($0.04) | ($4.45) | ($0.21) | $0.23 | $0.74 | $0.11 | $0.46 | $0.13 |
| Shares outstanding (diluted) | 27.8 | 26.5 | 26.2 | 27.4 | 26.2 | 25.0 | 23.9 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|